Mannose-Functionalized Fe3O4-Polyamidoamine Dendrimer Nanocomplexes with Unusual T1 MRI Response for Targeted Atherosclerosis Imaging
Atherosclerosis continues to represent a significant risk underlying many cardiovascular events. Developing clinically adaptable imaging of atherosclerosis could be effective in diagnosing and monitoring the progression of atherosclerosis or its response to therapy. Iron oxide nanoparticles are widely studied as T2-weighted magnetic resonance imaging (MRI) contrast agents, generating dark, negative signals. However, their potential as T1-weighted agents, despite the clinical advantages of producing bright, positive signals critical for vascular imaging, has remained largely underexplored, particularly in the context of atherosclerosis. In this work, we report on the development of mannose-functionalized Fe3O4-polyamidoamine (PAMAM) dendrimer nanocomplexes, which possess unusual T1-weighted MRI contrast property. It is confirmed that ultrasmall Fe3O4 nanoparticles under 5 nm are uniformly distributed in the PAMAM matrix and act as a “cross-linker,” forming a complex with a size of 70 nm. This mannose-decorated nanocomplex produces an enhanced T1-weighted signal in in vivo studies, with a 12% signal increase in atherosclerotic plaques, indicating its potential clinical use for targeted imaging of atherosclerosis and the development of a theranostic platform.
Authors
- Huari Kou
- James D. Quirk (ORCID: https://orcid.org/0000-0002-6118-7097)
- Hu Yang (ORCID: https://orcid.org/0000-0003-3030-004X)
- Lin Qi
Institutions
- Marquette University (US)
- Missouri University of Science and Technology (US)
- Medical College of Wisconsin (US)
- Washington University in St. Louis (US)
Publication Details
- Journal
- ACS Nano Medicine
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1021/acsnanomed.6c00255
- Primary Topic
- Characterization and Applications of Magnetic Nanoparticles
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Heart, Lung, and Blood Institute